Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach.
Jessica OchalekHaiyin WangYuanyuan GuJames LomasHenry CutlerChunlin JinPublished in: PharmacoEconomics (2021)
Our results suggest that the current cost-effectiveness threshold used in China is too high; continuing to use it risks decisions that reduce overall population health.